e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): May 27, 2011
EXPRESS SCRIPTS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
DELAWARE
(State or Other Jurisdiction of
Incorporation or Organization)
|
|
0-20199
(Commission File Number)
|
|
43-1420563
(I.R.S. Employer
Identification No.) |
|
|
|
One Express Way, St. Louis, MO
(Address of Principal Executive Offices)
|
|
63121
(Zip Code) |
Registrants telephone number including area code: 314-996-0900
No change since last report
(Former Name or Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
|
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 1.01 Entry into a Material Definitive Agreement.
On May 27, 2011, Express Scripts, Inc. (the Company) entered into two letter agreements
(together, the ASR Agreements) with Morgan Stanley & Co. Incorporated (Morgan Stanley) to
purchase shares of its common stock for an aggregate purchase price of $1,750 million (Purchase
Price), pursuant to the Companys share repurchase program approved by the Companys Board of
Directors. The Company will finance the repurchases with cash on hand, including with the proceeds
from its recently completed offering of $1,500 million in aggregate principal amount of 3.125%
Senior Notes due 2016. The Company expects to cancel the repurchased shares.
When the Company pays the Purchase Price on May 27, 2011, it will receive from Morgan Stanley
approximately 29.4 million shares of the Companys common stock (the Initial Shares), which
number is equal to the Purchase Price divided by the closing stock price of the Companys common
stock on the Nasdaq Global Select Market on May 26, 2011. At the end of the valuation period under
each ASR Agreement, there will be a settlement adjustment, such that (i) Morgan Stanley will
deliver to the Company a number of shares equal to the Purchase Price divided by a discounted
arithmetic mean of the daily volume-weighted average prices per share of the Companys common stock
during the ASR Agreements respective valuation periods (each such price at the end of the relevant
valuation period, the Forward Price), minus the number of Initial Shares; or (ii) if such
difference is less than zero, then the Company will be obligated to deliver to Morgan Stanley (x)
the number of shares equal to such difference, plus certain additional shares in an amount fixed in
the ASR Agreements at a certain percentage of such difference, or, at the Companys option, (y) the
value of such shares in cash, as calculated pursuant to the terms of, and paid pursuant to the
procedures set forth in, the ASR Agreements.
The valuation periods in the ASR Agreements begin on June 1, 2011, and are expected to end in the
fourth quarter of 2011. However, Morgan Stanley may accelerate the end of the valuation periods,
either in full or partially, under either ASR Agreement to an earlier date. Certain events, such
as market disruption events, legal, regulatory or self-regulatory requirements or related policies
and procedures, and certain extraordinary corporate events that do not result in termination of the
transactions, may result in the valuation periods being extended.
The ASR Agreements are subject to terms customary for similar agreements, including providing for
the effects of extraordinary corporate transactions and setting forth circumstances under which the
agreement may be terminated early, including if the price of the Companys common stock falls below
a threshold price set forth in the ASR Agreements. Such terms include, but are not limited to:
|
|
|
the required timing of delivery of shares, |
|
|
|
|
the specific circumstances under which Morgan Stanley is permitted to make adjustments
to the valuation periods; |
|
|
|
|
the specific circumstances under which the share repurchases may be terminated early, |
|
|
|
|
the specific circumstances under which Morgan Stanley may deliver fewer than the
specified number of shares, and |
|
|
|
|
various acknowledgments, representations and warranties made by the Company and Morgan
Stanley to one another. |
The foregoing description of the ASR Agreements is qualified in its entirety by reference to the
form of ASR Agreement, a copy of which is attached as Exhibit 10.1 and is incorporated herein by
reference.
In connection with the ASR Agreements, Morgan Stanley may buy or sell the Companys common stock or
derivative securities in hedging transactions, and may be active in the market for the Companys
common stock other than in connection with hedging activities in relation to the transaction.
Morgan Stanley and its affiliates have performed, and may in the future perform, various banking
and other financial advisory services for the Company and its subsidiaries for which they have
received, and will receive, customary fees and expenses.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The disclosure provided under Item 1.01 above is hereby incorporated by reference.
Item 7.01 Regulation FD Disclosure
On May 27, 2011, Express Scripts, Inc. issued a press release announcing its entry into two
accelerated share repurchase transactions. The press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference.
This information is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed
filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
Express Scripts, Inc.
|
|
|
By |
/s/ Keith J. Ebling
|
|
|
|
Name: |
Keith J. Ebling |
|
|
Title: |
Executive Vice President and General Counsel |
|
Dated: May 27, 2011
EXHIBIT INDEX
|
|
|
Exhibit No. |
|
Description |
10.1
|
|
Form of Confirmation relating to a Fixed Notional Accelerated
Share Repurchase Transaction between Express Scripts, Inc. and
Morgan Stanley & Co. Incorporated. |
|
|
|
99.1
|
|
Press Release, dated May 27, 2011. |